4//SEC Filing
Brady Todd C 4
Accession 0000950170-25-034674
CIK 0001341235other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:17 PM ET
Size
5.5 KB
Accession
0000950170-25-034674
Insider Transaction Report
Form 4
Brady Todd C
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2025-03-04+809,710→ 809,710 totalExercise: $6.17Exp: 2035-03-03→ Common Stock (809,710 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2025.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001579179
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:17 PM ET
- Size
- 5.5 KB